DENOUEMENT AND DISCUSSION Infantile Hepatic Hemangioendothelioma
The abdominal CT, sonogram and aortogram demonstrated multicentric vascular tumors of the liver with marked arteriovenous shunting. The flow from the aorta was seen to be primarily into an enormous hepatic artery supplying the hepatic lesions. This is the typical appearance of infantile hepatic hemangioendothelioma (IHHE). Subsequent treatment included a month's trial of interferon 2a alone, but with worsening symptoms. The child then was treated with a 2-week course of steroids, but again without any improvement. Congestive heart failure was managed with furosemide, spironolactone and digitoxin. At this time, the child was transferred to St. Louis Children's Hospital for consideration of liver transplant. However, hepatic arterial embolization and embolization of the right phrenic artery and internal mammary arteries were initially performed. These procedures led to improvement in congestive heart failure. The child has subsequently continued to slowly improve and has been returned to the home hospital.
Infantile hepatic hemangioendothelioma is the most common hepatic vascular lesion of infants. Ninety-five percent of patients present before the first year of life and 80% to 90% present within the first 6 months of life. Although there is no known genetic basis for this lesion, IHHE occurs twice as frequently in females as in males.
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The serum alpha-fetoprotein level is usually normal, but occasionally may be elevated. 4 Characteristically, IHHE consists of multiple densely vascular masses with tangled vascular channels and marked arteriovenous shunting. The classic clinical triad of patients with IHHE consists of hepatomegaly, congestive heart failure and cutaneous hemangiomas. Although hepatomegaly occurs in almost all patients, congestive heart failure and cutaneous hemangiomas each occur in only 50% of patients. 2 Additional problems or complications seen in patients with IHHE include thrombocytopenia, Kasabach±Merritt syndrome, hepatic calcifications (50% by CT), anemia, portal hypertension, obstructive jaundice, symptomatic hemangiomas in the brain and bowel and a rare risk (probably less than 5%) of malignant degeneration to angiosarcoma with metastases. 5 ± 7 IHHE has a characteristic growth pattern that includes rapid growth in the months immediately following presentation. However, the lesion spontaneously regresses and resolves by 12 to 18 months of age if the patient can be supported. 6 IHHE is associated with a high mortality and morbidity. Untreated, there is 85% mortality; with supportive care, only 65% mortality, and with therapy directed toward reducing the lesion size and/or its blood supply, a 20% mortality. 6 Two histologic varieties are described: type 1 with immature plump endothelial cells and type 2 with very immature, pleomorphic cells and a more aggressive behavior. 8 Imaging techniques demonstrate multiple hepatic lesions which are hypoechoic by sonography and hypodense by contrast-enhanced CT. On magnetic resonance imaging, the lesions are hypodense except for areas of hemorrhage on T1-weighted sequences, and hyperintense on T2-weighted sequences except for areas of calcification. . At the level of the superior mesenteric artery ( arrowheads ), the aorta is quite small.
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Infantile Hepatic Hemangioendothelioma markedly diminish in size after the take off of the celiac axis or hepatic artery, which is the main source of blood supply to the lesions. The treatment of IHHE depends on the severity of congestive heart failure, which in turn depends upon the tumor size, and growth pattern. 3 Supportive medical management includes diuretics and digitalis. Children who do not respond to medical management have a poor prognosis of long-term survival. 7 More aggressive medical treatment includes steroids, 2a-interferon as an anti±angiogenic agent, chemotherapy (adriamycin) and radiation therapy. Interferon 2a is known to inhibit capillary endothelial proliferation. 2 Its efficacy is uncertain because of the propensity for spontaneous regression of hepatic vascular lesions. Interventional and surgical management include hepatic artery ligation, hepatic artery embolization, partial hepatic resection and liver transplant. 5 Hepatic artery ligation and embolization alone is met with inconsistent results. This is because additional blood supply to the lesion is present in many cases. Collateral supply is commonly from the superior mesenteric artery, intercostal arteries, phrenic artery, and internal mammary arteries as in this case and from the portal venous flow. 6 Portal venous and collateral arterial supply to the lesions may be much more common than previously believed. 
